.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Modern medical diagnostics are currently making significant strides toward personalized care. A groundbreaking study reveals how a disease trajectory blood test can predict patient outcomes from just one sample. Researchers at Imperial College London recently developed the VeloCD method for this purpose. This tool analyzes RNA markers to determine if a patient will recover or deteriorate soon. Consequently, doctors can see if an infection is ramping up or winding down without repeated tests.
This innovative approach helps in identifying the specific cause of a fever. For instance, it distinguishes between bacterial and viral origins very efficiently. Furthermore, it accurately assessed children with acute fevers across nine European countries. Specifically, it predicted transitions in healthy adults exposed to flu or COVID-19 pathogens. By predicting the course of illness early, clinicians can provide more targeted treatments. Therefore, the right patient receives the right care at the most optimal time.
Moreover, the test requires only a single time-point sample to yield results. This efficiency reduces the need for repeated measurements over several days significantly. As a result, healthcare staff can triage patients much faster than traditional methods allow. Additionally, the test predicted treatment responses in inflammatory bowel disease after just one dose. Furthermore, the study appeared in the journal Nature Communications recently. However, the team notes that further validation is still necessary before widespread clinical use.
Q1: What is the VeloCD method?
The VeloCD method is a computational approach that analyzes whole-blood RNA to anticipate future clinical states from a single time-point sample.
Q2: Can the test help with COVID-19 and flu?
Yes, the study showed that blood samples collected as early as Day 2 after exposure could accurately predict infection before PCR confirmation.
Q3: Who led the development of this technology?
Researchers from the UK\'s Imperial College London led the study and developed the VeloCD method as a proof-of-concept diagnostic tool.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Imperial College London researchers develop VeloCD, a blood test predicting illness trajectory and treatment response using RNA velocity from one sample....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
